Endo Int'l (ENDP) Tops Q2 EPS by 20c, Offers FY Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Tech stocks pull Wall Street lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Endo Reports Second-Quarter 2017 Financial Results
August 8, 2017 6:30 AM EDTDUBLIN, Aug. 8, 2017 /PRNewswire/ -- Â
Second-quarter 2017 revenues of $876 million and reported $3.12 diluted (GAAP) loss per share from continuing operations Second-quarter 2017 Branded Specialty Products revenues increased 16 percent to $110 million Second-quarter 2017 Sterile Injectables revenues increased 27 percent to $161 million Second-quarter 2017 adjusted diluted earnings per share (EPS) from continuing operations increased 8 percent to $0.93 Second-quarter 2017 reported (GAAP) consolidated net loss of $1,397 million, including $775 million to increase the mesh product liability accrual primarily related to the resolution of virtually all known U.S. mesh product liability claims Second-quarter 2017 adjusted... More